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The butyl and isopropyl derivatives (4I, 5Br) of chiral pool derived bis-imidazolium dehydrohexitol salts
have been prepared. The ditopic N-heterocyclic carbenes 4 and 5 form dinuclear Ag(I) and Pt(II)
complexes. All compounds were fully characterised by multinuclear NMR spectroscopy. The bis-
imidazolium salt 4I and platinum complexes cis-[Pt2(μ-2)(dmso)2Cl4] and cis-[Pt2(μ-4)(dmso)2Cl4] were
characterised by X-ray crystallography. In the case of the Pt(II) complexes, the carbene ring is positioned
in a sterically preferred orientation, approximately perpendicular to the platinum coordination plane. The
1H, 13C, 15N and 195Pt NMR spectra of the platinum complexes show the presence of rotamers due to
hindered rotation about the carbene–metal bond.
Introduction
N-Heterocyclic carbene (NHC) ligands and their transition metal
complexes have established themselves as a cornerstone of
modern coordination chemistry and are now used in a wide
range of applications. Platinum(II)–NHC complexes in particular
catalyse a number of important reactions, such as hydrosilyla-
tions,1 hydroaminations,2 tandem hydroboration-cross-coupling
reactions3 and diboration of unsaturated molecules.4 Platinum(II)–
NHC complexes have also seen recent activity in medicinal
applications as possible chemotherapeutic agents.5 Thus efﬁcient
syntheses of platinum–NHC complexes are of considerable
current interest. Synthetic routes to Pt–NHC complexes include
direct reaction of the carbene precursor in the presence of
base,1e,6 or of the free carbene, with suitable platinum salts.7
Alternatively, transmetalation of Ag–NHC complexes with a
platinum source is also known.8
Silver(I) carbenes are extensively used as ligand transfer
agents for the majority of imidazolium and other azolium salts,
forming a part of a convenient, and sometimes the only, route for
the synthesis of metal carbene complexes.9 Ag(I)–NHC com-
plexes have also found many medicinal applications, mainly due
to their activity as antimicrobials.10 Other potential uses include
high-end materials applications, such as luminescent chemo-
sensors.11 Silver–carbene complexes are structurally diverse, dis-
playing a broad range of coordination motifs, ranging from
simple two-coordinate linear molecules9e,12 to helicates,13 poly-
mers,14 rings,15 cages16 and clusters.17
Based on our previously reported chiral pool derived dehydro-
hexitol framework precursor 1,18 we recently described an
efﬁcient method leading to the bis-carbene precursor imidazo-
lium salts 2X (Scheme 1) with 2,5-exo stereochemistry.19 The
endo and exo stereochemistry refers to the substitution with
respect to the bent V-shaped core of the fused dehydrohexitol
ring. Here we report the synthesis of the isopropyl- and butyl-
imidazole derivatives (4X and 5X) following an alternative syn-
thetic route and expand on the coordination chemistry for this
family of bridging NHC ligands, to include examples of their
Pt(II) complexes.
Discussion
The 2,5-exo-bisimidazole 3 was prepared from the reaction of
ditosylate 1 with imidazole in dmf in the presence of Cs2CO3
(Scheme 1). Subsequent quaternerisation with the corresponding
alkyl halide afforded the bis-isopropyl- and butyl-imidazolium
salts 4I and 5Br. Following counterion metathesis with potass-
ium hexaﬂuorophosphate in water, 4PF6 is furnished as a crystal-
line white solid and 5PF6 as a colourless viscous ionic liquid.
The imidazolium salts have the expected exo stereochemistry at
the 2 and 5 positions of the bicyclic ring as in the parent hexitol,
L-iditol. The dicationic salts are readily soluble in water and
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polar organic solvents such as lower alcohols, acetone, aceto-
nitrile and dmso. Single crystals of 4I suitable for X-ray studies
were grown from an acetonitrile solution of the salt, and the
structure of the cation is shown in Fig. 1.
Silver(I) complexes
The silver(I) complexes of carbenes 4 and 5 were prepared from
the reaction of Ag2O with the corresponding imidazolium salts,
4I, 4PF6 and 5Br. NHC carbenes 4 and 5 form the bridged
metallacyclic dinuclear silver complexes, [Ag2(μ-NHC)2][X]2
shown in Scheme 1, irrespective of the metal to ligand ratio and
type of counterion used. The analogous methyl–imidazolyl
complex [Ag2(μ-2)2][PF6]2 and its solid-state structure has been
reported previously by us.19 Unfortunately, the isopropyl and
butyl derivatives, 6I and 7Br, did not afford good crystals of
sufﬁcient quality to allow for their X-ray structure determi-
nations. As was the case for NHC ligand 2, the neutral acyclic
bis-monocarbene complexes (11) were not observed. Electro-
spray mass spectra show maximal mass peaks at m/z 1001 and
1009 for the silver metallacycle complexes, 6I and 7Br respect-
ively, corresponding to loss of one of the counterions from the
parent compound, [Ag(μ-NHC)]2[X]2. In the
13C NMR spectra
of the silver complexes the carbene resonance appears as a sharp
Scheme 1 Reagents and conditions. (a) N-Methylimidazole, 140 °C; (b) Cs2CO3, dmf, 100 °C; (c) 4I: excess isopropylbromide, CH3CN, reﬂux,
5Br: excess butylbromide, dmf, 100 °C; (d) excess KPF6, H2O; (e) Ag2O, CH2Cl2, room temperature, 2 days; (f/g) K2PtCl4 or PtCl2, NaOAc, dmso,
70 °C, 2 days.
Fig. 1 Displacement ellipsoid plot at the 50% probability level of the
bis-imidazolium cation of 4I. The iodide anions are omitted for clarity.
Selected bond lengths (Å) and angles (°): N1–C2 1.333(5), C2–N3
1.341(5), N17–C18 1.331(5), C18–N19 1.329(5), N1–C2–N3 109.3(4),
N17–C18–N19 109.5(3).
12840 | Dalton Trans., 2012, 41, 12839–12846 This journal is © The Royal Society of Chemistry 2012
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singlet at δ 180.6 ppm for 6I and δ 181.6 ppm for 7Br. Coupling
to 107Ag or 109Ag was unobserved in both cases. Silver–carbene
complexes have been used previously in transmetalation reac-
tions with platinum(II) salts to afford the corresponding Pt(NHC)
complexes.8b,20 In the case of the silver complex 7Br reaction
with Pt(cod)Cl2 afforded mixtures of Pt(II)-containing species
and partially protonated carbene ligand.
Platinum(II) complexes
In order to avoid time- and resource-consuming routes, the plati-
num complexes 8–10 were prepared directly from the reaction of
the corresponding ligand salts (2PF6, 4PF6 and 5PF6) with
PtCl2 or K2PtCl4 in quantitative yields (Scheme 1). Reactions
were carried out in the presence of NaOAc in dmso, under
aerobic conditions using unpuriﬁed technical grade solvent.
Reactions in other solvents, e.g. dma (N,N′-dimethylacetamide),
afforded complex mixtures of intractable products. The above
synthetic procedure afforded the bis-monocarbene complexes,
cis-[Pt2(μ-NHC)(dmso)2Cl4], regardless of the metal to ligand
ratio used.7,8,20 1 : 1 metal to ligand reactions afforded the corre-
sponding cis-[Pt2(μ-NHC)(dmso)2Cl4] complexes, with the
excess imidazolium salt remaining unreacted. Complexes 8–10
are air- and moisture-stable and can be stored for prolonged
times in air without any visible decomposition. They are soluble
in chlorinated solvents, acetonitrile and dmso.
Solution NMR measurements
Relatively small changes are observed in the 1H NMR spectra
for the hydrogen atoms of the proligands of 2, 4 and 5 upon
coordination to silver(I). More pronounced deshielding of the
proton resonances, however, is seen for the platinum complexes,
most likely due to the divalent metal. Notably, there are large
downﬁeld shifts of the methine protons (H2/5) adjacent to the
imidazolyl nitrogen atoms from ca. δ 5.1 ppm (CD3CN) in the
imidazolium salts to δ 5.9–6.1 ppm (CD3CN) in the coordinated
ligands. A large downﬁeld shift is also observed for the isopro-
pyl methine proton of 9, from δ 4.73 ppm in 4I to 5.63 ppm
(CD3CN).
Restricted rotation about the C–Pt bond
The 1H and 13C NMR spectra of the platinum complexes, 8–10,
reveal more than one isomers present in solution which have
been attributed to rotamers arising from restricted rotation about
the Pt–CNHC bond. High metal–carbene rotation barriers (>92 kJ
mol−1) have been observed for Rh(I)– and Ir(I)–NHC systems
and attributed mainly to steric effects.21 Similarly, for Pt(NHC)
(dmso)Cl2-type complexes Rourke et al. have reported barriers
to rotation in excess of 85 kJ mol−1.8a
In the case of the dinuclear complexes, 8–10, there are three
possible rotamers arising from slow rotation about the Pt–CNHC
bond; two of C2 symmetry with the dmso ligands either
in (isomer A, Scheme 1) or out (isomer B) with respect to the
dehydrohexitol core, and one of C1 symmetry with in and out
dmso ligands (isomer C). All three rotamers of 8–10 were
observed in different ratios, although due to the complexity of
the overlapping signals, these rotamers could not be individually
assigned. One common feature in the spectra of the complexes,
supporting the existence of three isomers in solution, is the
appearance of four distinct doublets for one of the imidazolyl
proton resonances, with one doublet for each of the C2 sym-
metric isomers and two doublets for the C1 symmetric isomer.
In addition, the two methyl groups of the coordinated dmso
are diastereotopically inequivalent, as of course are the methyls
on the isopropyl group of 9. In an attempt to simplify the
1H NMR spectra, a dmso-d6 solution of complex 8 was heated
to 100 °C. However, no signiﬁcant changes in the chemical
shifts were observed, leading us to conclude that a high barrier
to rotation about the Pt–CNHC bond also exists for these
complexes.
In the 195Pt NMR spectra of complexes 8–10 two signals were
observed in each case, centred at ca. −3500 ppm (referenced to
Na2PtCl6).
22 Presumably, some of the rotamer signals remain
unresolved in the corresponding 195Pt NMR spectra. For com-
parison, the δ195Pt reported for the related carbene complexes,
[Pt(NHC)(dmso)Me2], are in the region of −3900 to
−4000 ppm.20 The effect of the different N-imidazole substitu-
ents (Me, iPr, Bu) of complexes 8–10 on the 195Pt NMR chemi-
cal shifts (δ195Pt) is negligible. This is in agreement with
reports for other PtCl2 systems, such as those of chelating dipyri-
dyl ligands.23 Due to solubility limitations, different solvents
were used for each complex during these measurements
(dmso-d6 for 8, CD3CN for 9 and CD2Cl2 for 10). Contrary to
previous observations, where large Δδ195Pt of ca. 400 ppm were
observed with changes in the solvent from CD2Cl2 to dmso-d6,
there were no signiﬁcant solvent effects observed for complexes
8–10.24
1H–15N HMBC spectra were also collected for the platinum
complexes. In most cases analyses of the cross-peaks in the two-
dimensional spectra provided a means of differentiating and
assigning the two non-symmetrically substituted imidazolyl 15N
resonances. Relatively small differences in the chemical shifts of
the imidazole derived nitrogens were observed (Δδ 15N), with the
largest Δδ 15N observed for complex 9 at 16 ppm and the smal-
lest for complex 10. In this case, the two 15N resonances centred
at 204.5 ppm remained unresolved. Although the signals for NO
and NR in the 15N dimension of the spectra for 8–10 were not
resolved further, the presence of rotamers is implied after inspec-
tion of the cross-section of the peaks in the 2D-spectra (where
NO represents the nitrogen atom next to the oxolane ring and NR
the one next to the corresponding alkyl substituent).
Solid state structures of the Pt(II) complexes. The solid-state
structures of platinum complexes 8 and 9 were determined by
synchrotron X-ray crystallography. Complexes 8 and 9 adopt the
same C2 symmetric spatial arrangement shown in Fig. 2, with
complex 9 containing a true C2 crystallographic axis. The two
platinum centres are trans to each other, facing away from the
This journal is © The Royal Society of Chemistry 2012 Dalton Trans., 2012, 41, 12839–12846 | 12841
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dehydrohexitol core and the dmso ligands assume a syn arrange-
ment facing towards the core (isomer A, vide supra). This more
crowded conformation may be stabilised by non-classical
C–H⋯O hydrogen bonding interactions between the dmso
oxygen and bridgehead hydrogen atoms of the dioxolane unit;
for complex 9 the relevant O⋯H distances are 2.54 and 2.46 Å,
and for 8, 2.47 Å (two distances equal by symmetry).25 The
Pt–CNHC bonds are in the range 1.88(2)–1.98(2) Å, at the lower
end of the range reported for other Pt–NHC–dmso complexes.7,8
The carbene ring is placed in a sterically preferred orientation,
approximately perpendicular to the platinum coordination plane
in each case; the corresponding dihedral angles between the imi-
dazole and coordination planes are 81.9° for 8, and 86.2° and
89.7° for 9.
Experimental
General remarks
All manipulations were performed using standard glassware
under aerobic conditions, except where otherwise noted. Sol-
vents of analytical grade and deuterated solvents for NMR
measurements were used as received. Literature methods were
employed for the synthesis of 119 and Ag2O.
26 All other reagents
were used as received. Ether means diethyl ether and dmf
dimethylformamide unless speciﬁed otherwise. NMR spectra
were obtained on Bruker Avance AMX 250, 400, 500, 600 (QCI
Quadruple Resonance CryoProbe) or Jeol Eclipse 300 spectro-
meters. The chemical shifts are given as dimensionless δ values
and are frequency referenced relative to TMS for 1H and 13C and
Na2PtCl6 for
195Pt. For 1H–15N heteronuclear multiple-bond
correlation (HMBC) experiments, CH3NO2 was used as the stan-
dard for the 15N chemical shifts (δ = 381.7 vs. liquid NH3).
27 In
the HMBC experimental, NR stands for the alkyl substituted
nitrogen of the imidazole ring and NO for the one next to the
dioxolane ring.
Coupling constants J are given in hertz (Hz) as positive values
regardless of their real individual signs. The multiplicity of the
signals is indicated as s, d, or m for singlets, doublets, or multi-
plets, respectively. The abbreviation br is given for broadened
signals. Mass spectra and high-resolution mass spectra were
obtained in electrospray (ES) mode unless otherwise reported,
on a Waters Q-Tof micromass spectrometer. IR spectra were
measured on a JASCO 660plus FT-IR spectrometer from 4000
to 600 cm−1.
1,4:3,6-Dianhydro-2,5-dideoxy-2,5-bisimidazole-L-iditol, 3. 1
(9.1 g, 20.0 mmol) was dissolved in dmf (20 mL). Imidazole
(2.9 g, 42.9 mmol) and caesium carbonate (16.3 g, 50.0 mmol)
were added to the solution and the reaction temperature main-
tained at 100 °C for 1 day. A saturated brine solution (150 mL)
was added to the reaction vessel and stirred until the yellow solid
that formed had dissolved. The product was extracted with
dichloromethane (3 × 50 mL) and dried over MgSO4. The solu-
tion was ﬁltered and solvent removed by reduced pressure to
leave a white solid. The solid was washed with ether and dried.
Yield: 3.9 g, 79%. 1H NMR (250 MHz, dmso-d6): 4.17 (dd, J =
10.5, 2.4, 1H, endo-H1/6), 4.25 (dd, J = 10.5, 4.9, 1H, exo-H1/6),
4.75 (s, 1 H, H3/4) 4.87 (dd, J = 4.7, 2.4 Hz, 1H, H2/5), 7.01 (d,
J = 1.0, 1H, imid-H) 7.02 (d, J = 1.0, 1H, imid-H), 7.45 (s, 1H,
CNHCH).
13C NMR (75 MHz, CDCl3) δ ppm 63.00 (C
2/5), 72.75
(C1/6), 88.23 (C3/4), 117.27 (imid-C), 130.66 (imid-C), 135.95
(CNHC).
15N NMR (from 1H–15N HMBC, 600 MHz, CDCl3)
δ ppm −122.5 (NR), 191.2 (NO). MS (AP+) m/z (%):
[M+], [C12H15N4O2]
+ 247.1195; measured: 247.1183 (100);
[MH + CH3CN
+], 288.1459.
1,4:3,6-Dianhydro-2,5-dideoxy-2,5-bis(3-isopropyl imidazo-
lium)-L-iditol iodide, 4I. The bis-imidazole 3 (1.4 g, 5.7 mmol)
was dissolved in acetonitrile (15 mL), followed by the addition
of isopropyliodide (1.5 mL, 15.0 mmol). The mixture was
reﬂuxed for 1 day and subsequently left to cool to room tempera-
ture. The product crystallised out of the reaction solution and
was subsequently ﬁltered under suction and dried in air.
Yield: 2.6 g, 69%. 1H NMR (400 MHz, D2O): δ ppm 1.44
Fig. 2 Displacement ellipsoid plots at the 50% probability level of the
platinum complexes 8 (above) and 9; for clarity only some of the
H atoms are shown. Selected bond lengths (Å) and angles (°) for 8: Pt–
Cl(1) 2.361(8), Pt–Cl(2) 2.305(8), Pt–S 2.205(7), Pt–C(1) 1.98(2),
Cl(1)–Pt–Cl(2) 90.0(3), Cl(1)–Pt–S 90.4(3), Cl(1)–Pt–C(1) 176.1(8),
Cl(2)–Pt–S 178.9(3), Cl(2)–Pt–C(1) 88.4(6), S–Pt–C(1) 91.2(6). Selected
bond lengths (Å) and angles (°) for 9: Pt(1)–Cl(1) 2.335(4), Pt(1)–Cl(2)
2.328(4), Pt(1)–S(1) 2.189(4), Pt(1)–C(5) 1.948(14), Pt(2)–Cl(3)
2.338(4), Pt(2)–Cl(4) 2.306(4), Pt(2)–S(2) 2.190(4), Pt(2)–C(16) 1.88(2),
Cl(1)–Pt(1)–Cl(2) 90.86(13), Cl(1)–Pt(1)–S(1) 90.88(14), Cl(1)–Pt(1)–
C(5) 177.1(4), Cl(2)–Pt(1)–S(1) 175.60(14), Cl(2)–Pt(1)–C(5) 88.3(4),
S(1)–Pt(1)–C(5) 90.2(4), Cl(3)–Pt(2)–Cl(4) 90.62(18), Cl(3)–Pt(2)–S(2)
91.02(18), Cl(3)–Pt(2)–C(16) 176.0(5), Cl(4)–Pt(2)–S(2) 178.04(16),
Cl(4)–Pt(2)–C(16) 88.3(5), S(2)–Pt(2)–C(16) 90.1(5).
12842 | Dalton Trans., 2012, 41, 12839–12846 This journal is © The Royal Society of Chemistry 2012
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(d, 6H, J = 6.7, CHMe2), 4.30 (m, 2H, H
1/6), 4.56 (m, 1H,
CHMe2), 5.10 (s, 1H, H
3/4), 5.15 (m, 1H, H2/5), 7.45 (br s, 1H,
imid-H), 7.55 (br s, 1H, imid-H), 8.86 (s, 1H, CNHCH).
13C
NMR (125 MHz, D2O) δ ppm 22.2 (CHMe2), 53.9 (CHMe2),
65.0 (C2/5), 72.1 (C1/6), 87.3 (C3/4), 121.3 (imid-C), 121.7 (imid-
C), 134.0 (CNHC). MS (ES
+) m/z: [M − I]+, [C18H27N4O2127I]+:
459.1262; measured: 459.1262 (30); [MH − 2I]+, 331.2138
(40). Anal. Calcd for C18H28I2N4O2 (586.25): C, 36.88; H, 4.81;
N, 9.56. Found: C, 36.78; H, 4.79; N, 9.42.
1,4:3,6-Dianhydro-2,5-dideoxy-2,5-bis(3-isopropylimidazolium)-
L-iditol hexaﬂuorophosphate (4PF6). An aqueous solution of
KPF6 (2.2 g, 12.0 mmol) was added slowly to a 20 mL aqueous
solution of the bis-iodide salt 5I (1.9 g, 3.2 mmol). Immediately
a white solid precipitated; it was collected by ﬁltration. The solid
was washed with cold ethanol and ether and left to dry under
suction. Yield: 1.8 g, 91%. 1H NMR (250 MHz, dmso-d6): δ =
1.50 (d, J = 6.7, 6H, CHMe2), 4.33 (m, 2H, CH2), 4.70 (m, 1H,
CHMe2), 5.10 (s, 1H, CH), 5.25 (m, 1H, CH) 7.80 (s, 1H, imid-
H), 8.05 (s, 1H, imid-H), 9.25 (s, 1H, CNHCH); δ
13C NMR
(100 MHz, D2O) δ = 22.29 (CHCH3), 53.92 (CHCH3), 65.05
(C2/5), 72.13 (C1/6), 87.36 (C3/4), 121.34 (imid-C), 121.75 (imid-
C), 133.99 (CNHC); IR (KBr) 844 (s), 1097 (m), 1160 1182 (m),
1555 (m), 2906 (w), 3172 (sh, m), 3423 (br, w).
1,4:3,6-Dianhydro-2,5-dideoxy-2,5-bis(3-butyl imidazolium)-L-
iditol bromide (5Br). Bis-imidazole 3 (0.526 g, 2.14 mmol) was
dissolved in dimethylformamide (4 mL), followed by addition of
excess butylbromide (4.2 g, 31.0 mmol). The mixture was
heated to 100 °C for 2 days and subsequently left to cool to
room temperature. Volatiles were evaporated and the residue was
dissolved in hot CH3CN. After storing for one day at −5 °C
colourless crystals of the product were obtained. Yield: 0.805 g,
73%. 1H NMR (250 MHz, CDCl3) δ ppm 0.98 (t, J = 7.3, 3H,
CH3), 1.43 (m, J = 7.3, 2H, CH2), 1.94 (m, J = 7.5, 2H, CH2),
4.34 (m, 3H, NCH2/H
1/6), 4.54 (dd, J = 4.50, 1H, H1/6), 5.71 (br
s, 1H, H2/5), 5.77 (br s, 1H, H3/4), 7.46 (s, 1H, imid-H), 8.28 (s,
imid-H, 1H), 10.22 (s, 1H, CNHCH).
13C NMR (75 MHz,
CD3Cl): δ = 13.57 (CH3), 19.64 (CH2), 32.02 (CH2), 50.20
(NCH2), 64.96 (C
2/5), 72.34 (C1/6), 87.17 (C3/4), 122.24 (CH),
122.93 (CH), 136.8 (CNHC).
15N NMR (from 1H–15N HMBC,
600 MHz, CDCl3) δ ppm 201.0 (N
O), 202.3 (NR). MS (ES+)
m/z: [M − Br]+, [C20H32BrN4O2]+: 439.17 (30). Anal. Calcd for
C20H32Br2N4O2 (520.30): C, 46.17; H, 6.20; N, 10.77. Found:
C, 46.07; H, 6.23; N, 10.66.
1,4:3,6-Dianhydro-2,5-dideoxy-2,5-bis(3-butylimidazolium)-L-
iditol hexaﬂuorophosphate (5PF6). An aqueous solution of
KPF6 (2.2 g, 12.0 mmol) was added slowly to a 20 mL aqueous
solution of the bis-bromide salt 5Br (0.527 g, 1.0 mmol). The
product separated from the solution as a colourless oil. This was
collected and dried to afford 0.353 g of the product. Yield:
0.353 g, 54%. 1H NMR (250 MHz, acetone-d6) δ ppm 0.96 (t,
J = 7.5, 3H, CH3) 1.39 (m, 2H, CH2), 1.96 (m, J = 7.5, 2H,
CH2), 4.40 (t, J = 7.5, 2H, NCH2), 4.52 (m, J = 2.2, 2H, H
1/6)
5.33 (s, 1H, H3/4) 5.42 (m, 1H, H2/5) 7.83 (m, J = 1.9, 1H, imid-
H), 7.90 (m, 1H, imid-H), 9.20 (s, 1H, CNHCH).
Preparation of [Ag2(μ-4)2]I2, 6I. 4I (0.59 g, 1 mmol) was dis-
solved in a 1/1 mixture of CH2Cl2/acetone (60 mL). Silver(I)
oxide (0.25 g, 1.1 mmol) was subsequently added to the solution
and the mixture was left stirring for 1 day. Then the solution was
ﬁltered through celite and dried. Yield: 0.814 g, 72%. 1H NMR
(400 MHz, dmso-d6): δ ppm 1.48 (d, J = 6.7, 6H, CHMe2), 1.49
(d, J = 6.4, 6H, CHMe2), 4.33 (m, 4H, H
1/6), 4.77 (m, 2H,
CHMe2), 5.01 (s, 2H, H
3/4), 5.30 (m, 2H, H2/5) 7.49 (m, 2H,
imid-H), 7.67 (m, 2H, imid-H). 13C NMR (75 MHz, dmso-d6):
δ ppm 23.85 (CHMe2), 54.21 (CHMe2), 66.73 (C
2/5), 72.72 (C1/6),
88.51 (C3/4), 119.53 (imid-C), 120.76 (imid-C), 180.62 (s,
CNHC). MS (ES
+, CH3CN): m/z (%), calcd mass for [M − I]+ =
[C36H52N8O4
107Ag2
127I]+ 1001.1258, measured: 1001.1306
(100).
Preparation of [Ag2(μ-4)2][PF6]2. 4PF6 (0.310 g, 0.50 mmol)
was dissolved in acetonitrile (1 mL). Silver(I) oxide (0.115 g,
0.5 mmol) was added to the solution along with sodium bromide
(0.27 g, 2.67 mmol) and the mixture heated to 100 °C for 1 day.
The solvent was removed to leave a waxy light yellow solid.
Yield: 0.443 g, 76%. 1H NMR (400 MHz, dmso-d6): δ ppm 1.44
(d, J = 6.7, 6H, CHMe2), 1.45 (d, J = 6.4, 6H, CHMe2), 4.32
(dd, J = 10.5, 5.3, 2H, endo-H1/6), 4.45 (br s, J = 10.5, 2H, exo-
H1/6), 4.72 (m, 2H, CHMe2), 4.95 (s, 2H, H
3/4), 5.29 (br s, 2H,
H2/5) 7.50 (d, J = 1.8, 2H, imid-H), 7.70 (d, J = 1.8, 2H, imid-
H); MS (ES+, CH3CN): m/z (%), calcd mass for [M − PF6]+ =
[C36H52N8O4F6P
107Ag2]
+ 1019.1855, measured 1019.1844
(100), 1033.1464 (15).
Preparation of [Ag2(μ-5)2]Br2, 7Br. The imidazolium salt 5Br
(0.390 g, 0.75 mmol) was dissolved in 30 mL of CHCl3, and
Ag2O (0.174 g, 0.75 mmol) was added to the solution. After
two hours the complex separated from the solution as an opaque
oil. Volatiles were evaporated and the foam obtained was dis-
solved in CHCl3 with heating, ﬁltered through celite and dried.
Yield: 0.557 g, 68%. 1H NMR (400 MHz, CD2Cl2) δ ppm 0.86
(t, J = 7.4, 6H, Me), 1.27 (m, J = 7.4, 4H, CH2), 1.73 (m, 4H,
CH2), 4.08 (t, J = 7.2, 4H, NCH2), 4.24 (dd, J = 11.0, 2.3, 2H,
endo-H1/6), 4.34 (dd, J = 11.0, 5.0, 2H, exo-H1/6), 4.97 (s, 2H,
H3/4), 5.20 (dd, J = 5.0, 2.3, 2H, H2/5), 7.02 (d, J = 2, 2H, imid-
H), 7.13 (d, J = 2, 2H, imid-H). 13C NMR (75 MHz, CD2Cl2): δ
ppm 13.52 (CH3), 19.84 (CH2), 33.46 (CH2), 52.24 (NCH2),
67.22 (C2/5), 72.76 (C1/6), 88.44 (C3/4), 119.42 (imid-C), 121.90
(imid-C), 181.26 (s, CNHC).
15N NMR (from 1H–15N HMBC,
600 MHz, CD2Cl2) δ ppm 211.3 (N
R), 212.5 (NO). MS (ES+)
m/z: [M − Br]+, [C40H60107Ag279BrN8O4]+: 1009.2023; measured:
1009.1985 (30).
For the 1H and 13C NMR spectra of the platinum complexes,
8–10 reported below, signals for all 3 observed isomers are
reported with individual peaks not assigned to a speciﬁc isomer.
Preparation of cis-[Pt2(μ-2)(dmso)2Cl4], 8. 2PF6 (0.187 g,
0.33 mmol), K2PtCl4 (0.278 g, 0.67 mmol) and NaOAc
(0.057 g, 0.70 mmol) were dissolved in 1 mL of dmso at 70 °C.
The reaction mixture was stirred at that temperature for 3 days.
The solution was dried under vacuum and the yellowish solid
obtained was washed three times with methanol and sub-
sequently dried. The white solid obtained was recrystallised by
diffusion of hexane into a dichloromethane solution to afford
block colourless plates of the product. Yield: 0.300 g (94%).
1H NMR (400 MHz, CD3CN) δ ppm 3.44/3.45/3.47/3.51/3.52/3.53
(s, 12H, Me2SO), 3.96/3.97/3.97/3.98 (s, 6H, Me), 4.14 (dd,
This journal is © The Royal Society of Chemistry 2012 Dalton Trans., 2012, 41, 12839–12846 | 12843
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J = 3.8, 7.2)/4.17 (dd, J = 3.2, 7.2)/4.20 (m)/4.23 (m, 2H, endo-
H1/6), 4.50 (m, 2H, exo-H1/6), 5.05 (br s, 2H, H3/4), 5.92/6.06
(m, 2H, H2/5), 7.08 (d, J = 2.3)/7.09 (d, J = 2.3)/7.12 (d, J =
2.1)/7.13 (d, J = 2.3, 2H, imid-H), 7.18 (br s, 2H, imid-H).
13C NMR (125 MHz, dmso-d6) δ ppm 37.61/37.64/37.71 (CH3),
65.80/65.90/66.05/66.11 (C2/5), 72.04/72.08/72.11/72.17 (C1/6),
87.48/87.56/87.75/87. 48 (C3/4), 118.54/118.69/118.82 (imid-C),
124.74/124.79 (imid-C), 143.60 (CNHC).
15N NMR (from
1H–15N HMBC, 600 MHz, dmso-d6) δ ppm 192.4 (N
R), 193.1
(NR), 203.2 (NO), 205.3 (NO). 195Pt NMR (107 MHz, dmso-d6)
δ ppm −3525, −3533. IR (KBr, νmax/cm−1) 1022 (s), 1092 and
1134 (s, SO). UV (CH3CN, 0.14 mM) 254 nm (intense dm
3
mol−1 cm−1), 300 nm (faint shoulder 1214 dm3 mol−1 cm−1).
MS (accurate mass, ES+, CH3CN) m/z (%), calculated mass for
[M + K]+, [C18H30Cl4KN4O4Pt2S2]
+: 1000.9360; measured:
1000.9361. Anal. Calcd for C18H30Cl4N4O4Pt2S2 (962.55):
C, 22.46; H, 3.14; N, 5.82. Found: C, 22.44; H, 3.13; N, 5.90.
Preparation of cis-[Pt2(μ-4)(dmso)2Cl4], 9. In a round bottom
ﬂask, K2PtCl4 (0.278 g, 0.67 mmol) and 4PF6 (0.208 g,
0.33 mmol) were dissolved in 2 mL of dmso. NaOAc (0.057 g,
0.70 mmol) was subsequently added, and the mixture heated to
70 °C for 1 day. The solution was dried in a Kügelrohr under
vacuum and the yellowish solid obtained was extracted with
CH3CN. The CH3CN washings were condensed to ca. 2 mL
volume and methanol was added to precipitate the complex as a
white solid. Complex 9 was recrystallised by storing a saturated
CH3CN/methanol solution of 9 at −5 °C. 1H NMR (400 MHz,
CD2Cl2) δ ppm 1.40 (m, 12H, CHMe2), 3.38/3.42/3.53/3.54
(s, 12H, Me2SO), 4.23 (dd, J = 11.4, 1.9, 2H, endo-H
1/6), 4.31
(dd, J = 11.4, 4.8)/4.37 (dd, J = 11.1, 5.6, 2H, exo-H1/6), 4.89
(d, 3J = 5)/4.93 (s)/5.01 (s)/5.07 (d, 3J = 5, 2H, H3/4), 5.56 (m,
2H, CHMe2), 5.81/6.16 (m, 2H, H
2/5), 6.89/6.90/6.95/6.97/
6.98–7.00 (m)/7.03 (d, 3J = 2.2, 4H, imid-H). 13C NMR
(125 MHz, CD3CN) δ ppm 20.78/20.80/20.93/20.95 (CHMe2),
44.52/44.59/44.66/44.71 (Me2SO), 52.77/52.82 (CHMe2),
65.63/65.74/65.93/66.03 (C2/5), 71.26/71.35/71.45/71.62 (C1/6),
86.87/86.94/87.11/87.26 (C3/4), 118.11/118.17/118.25/118.60
(imid-C), 118.57/118.60 (imid-C), 142.43/142.16 (CNHC).
15N
NMR (from 1H–15N HMBC, 600 MHz, CD3CN) δ ppm 202.1
(NO), 218.1 (NR). 195Pt NMR (107 MHz, CH3CN-d3) δ ppm
−3514, −3521. IR (KBr, νmax/cm−1) 1022 (m), 1096 and
1144 (s, SO). MS (ES+, CH3CN): m/z (%), calcd mass for
[M + K]+ = [C22H38Cl4KN4O4Pt2S2]
+ 1055.9971, measured
1055.9971 (22), 1000.09 (45). Anal. Calcd for C22H38Cl4-
N4O4Pt2S2 (1018.66): C, 25.94; H, 3.76; N, 5.50. Found: C, 25.
89; H, 3.81; N, 5.30.
Preparation of cis-[Pt2(μ-5)(dmso)2Cl4], 10. In a round bottom
ﬂask, PtCl2 (0.291 g, 1.1 mmol) and 5PF6 (0.353 g, 0.54 mmol)
were dissolved in 4 mL of dmso. NaOAc (0.097 g, 1.2 mmol)
was subsequently added, and the mixture heated to 65 °C for
2.5 days. The pale yellow solution was dried under vacuum and
the yellowish oil obtained was extracted with CHCl3 (2 ×
20 mL). The CHCl3 washings were condensed to afford a col-
ourless oil. Yield: 0.522 g, 93%. 1H NMR (400 MHz, acetone-
d6/dmso-d6) δ ppm 0.97 (t, J = 7.5, 6H, Me), 1.43 (m,
3J = 7.5,
4H, CH2), 1.99 (m, 4H, 2 × CH2), 3.60 (m, 12H, Me2SO), 4.12
(dd, J = 10.5, 4.2)/4.21 (m, J = 10.7, 3.4, 2H, endo-H1/6), 4.44
(m, 1H + 4H, CH2, exo-H
1/6), 4.63 (dd, J = 10.7, 5.1)/4.64 (dd,
J = 10.5, 4.2, 1H, exo-H1/6), 5.15 (m, 2H, H3/4), 6.02/6.12 (m,
2H, H2/5), 7.26 (d, J = 2.1)/7.29 (d, J = 2.1)/7.38 (d, J = 2.1)/
7.42 (d, J 2.1, 2H, imid-H), 7.51 (br s, 2H, imid-H). 13C NMR
(75 MHz, acetone-d6/dmso-d6) δ ppm 13.50 (CH3), 19.67
(CH3CH2), 32.03 (CH2), 50.41 (NCH2), 66.20/66.44/66.69
(C2/5), 72.17/72.23/72.41 (C1/6), 87.68/87.77/87.92 (C3/4),
118.49/118.80 (imid-C), 122.92/123.14/123.19 (imid-C),
144.15/144.31 (CNHC).
15N NMR (from 1H–15N HMBC,
600 MHz, CD2Cl2) δ ppm 204.5 (br s).
195Pt NMR (107 MHz,
CH2Cl2-d2) δ ppm −3518, −3521. MS (ES+) m/z: [M + Na]+,
[C24-H42
35Cl4
23NaN4O4
194Pt2
32S2]
+: 1065.0553; measured:
1065.0503 (20). Anal. Calcd for C24H42Cl4N4O4Pt2S2
(1046.71): C, 27.54; H, 4.04; N, 5.35. Found: C, 27.48; H, 3.97;
N, 5.49.
X-ray crystallography
Data for 4I were measured at 120 K on a Bruker Nonius
KappaCCD diffractometer at the window of a Bruker Nonius
FR591 rotating anode (λMo-Kα = 0.71073 Å) driven by
COLLECT and processed by DENZO software.28 The structure
was determined in SHELXS-97 and reﬁned using SHELXL-97.29
Data for 8 and 9 were obtained from very small and weakly dif-
fracting crystals by use of synchrotron radiation (λ = 0.6889 Å)
at 120 K, with a Crystal Logics kappa diffractometer and Rigaku
Saturn 724+ CCD detector at beamline I19 of Diamond Light
Source; software was Rigaku CrystalClear,30 and Bruker
APEX231 and SHELXTL.29 Key crystallographic data are shown
in Table 1.
In addition to the intended compound 9 (with 8 identical
molecules in the tetragonal unit cell, all of the same chirality),
the structure also contains highly disordered solvent and/or other
components that could not be modelled as discrete atoms and
could not be identiﬁed from the observed electron density distri-
bution. This has been treated with the SQUEEZE option of the
program PLATON.32 The reﬁned structural model contains only
the ordered part of the crystal structure and the unidentiﬁed dis-
ordered components are not included in any of the tabulated or
deposited values. The crystal structure of 8 contains disordered
dichloromethane solvent molecules, which it was possible to
model with discrete atom positions. For all three structures, the
correct enantiomer was conﬁrmed on the basis of signiﬁcant
anomalous scattering effects.33
Crystallographic data for all compounds have been deposited
with the Cambridge Crystallographic Data Centre as supplemen-
tary publications CCDC 893546–893548.
Conclusions
Short synthetic routes to the chiral, ether-functionalized NHC
precursors, 2OTs, 4I and 5Br have been developed. The brid-
ging ligands 2, 4 and 5 form either cationic dinuclear cyclic
structures with Ag(I) or neutral linear complexes in the case of
Pt(II). The robust nature of the Pt(II) complexes is indicated by
their synthesis being achieved under aerobic conditions using
bench grade solvents. For the cis-Pt(dmso)Cl2 complexes,
12844 | Dalton Trans., 2012, 41, 12839–12846 This journal is © The Royal Society of Chemistry 2012
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hindered rotation of the carbene ligand about the metal–NHC
bond is evident in their 1H, 13C, 15N and 195Pt NMR spectra,
where more than one rotamers can be observed.
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